// App-Quantinova.ai

: Treatment with ATYR1923 reduces biomarkers in COVID-19 pneumonia

Researchers

Presenter

  • Ryan Adams

Principal Investigators

  • Gennyne Walker

  • Lauren Guy

  • Lauren Sitts

  • Nelson Kinnersley

  • Lisa Carey

  • Leslie Nangle

  • Sanjay Shukla

Medical Centers

  • Octa Consulting Services, Harpenden, United Kingdom

  • Patara Pharma, LLC, San Diego, United States of America

Locations

  • United States

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Infectious Diseases (ID)

Disease

  • Severe COVID-19 pneumonia

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Randomized

  • Placebo Control

Phase

  • II

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved